{"id":147400,"date":"2022-02-24T05:23:13","date_gmt":"2022-02-24T05:23:13","guid":{"rendered":"https:\/\/www.healthbenefitstimes.com\/glossary\/?p=147400"},"modified":"2022-02-24T05:23:13","modified_gmt":"2022-02-24T05:23:13","slug":"epirubicin","status":"publish","type":"post","link":"https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/","title":{"rendered":"Epirubicin"},"content":{"rendered":"<p>A cytotoxic anthracycline antibiotic drug used in the treatment of solid tumours, acute leukaemia and lymphomas. It is related structurally to doxorubicin and is given intravenously, or by instillation into the urinary bladder\u00a0to treat bladder cancer under specialist supervision.<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>A cytotoxic anthracycline antibiotic drug used in the treatment of solid tumours, acute leukaemia and lymphomas. It is related structurally to doxorubicin and is given intravenously, or by instillation into the urinary bladder\u00a0to treat bladder cancer under specialist supervision. &nbsp;<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5],"tags":[],"class_list":["post-147400","post","type-post","status-publish","format-standard","hentry","category-e"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v21.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Epirubicin - Definition of Epirubicin<\/title>\n<meta name=\"description\" content=\"A cytotoxic anthracycline antibiotic drug used in the treatment of solid tumours, acute leukaemia and lymphomas. It is related structurally to doxorubicin and is given intravenously, or by instillation into the urinary bladder\u00a0to treat bladder cancer under specialist supervision.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Epirubicin - Definition of Epirubicin\" \/>\n<meta property=\"og:description\" content=\"A cytotoxic anthracycline antibiotic drug used in the treatment of solid tumours, acute leukaemia and lymphomas. It is related structurally to doxorubicin and is given intravenously, or by instillation into the urinary bladder\u00a0to treat bladder cancer under specialist supervision.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/\" \/>\n<meta property=\"og:site_name\" content=\"Glossary\" \/>\n<meta property=\"article:published_time\" content=\"2022-02-24T05:23:13+00:00\" \/>\n<meta name=\"author\" content=\"Glossary\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Glossary\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/\",\"name\":\"Epirubicin - Definition of Epirubicin\",\"isPartOf\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\"},\"datePublished\":\"2022-02-24T05:23:13+00:00\",\"dateModified\":\"2022-02-24T05:23:13+00:00\",\"author\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\"},\"description\":\"A cytotoxic anthracycline antibiotic drug used in the treatment of solid tumours, acute leukaemia and lymphomas. It is related structurally to doxorubicin and is given intravenously, or by instillation into the urinary bladder\u00a0to treat bladder cancer under specialist supervision.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Epirubicin\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#website\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/\",\"name\":\"Glossary\",\"description\":\"Difinitions\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}\"},\"query-input\":\"required name=search_term_string\"}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5\",\"name\":\"Glossary\",\"url\":\"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Epirubicin - Definition of Epirubicin","description":"A cytotoxic anthracycline antibiotic drug used in the treatment of solid tumours, acute leukaemia and lymphomas. It is related structurally to doxorubicin and is given intravenously, or by instillation into the urinary bladder\u00a0to treat bladder cancer under specialist supervision.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/","og_locale":"en_US","og_type":"article","og_title":"Epirubicin - Definition of Epirubicin","og_description":"A cytotoxic anthracycline antibiotic drug used in the treatment of solid tumours, acute leukaemia and lymphomas. It is related structurally to doxorubicin and is given intravenously, or by instillation into the urinary bladder\u00a0to treat bladder cancer under specialist supervision.","og_url":"https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/","og_site_name":"Glossary","article_published_time":"2022-02-24T05:23:13+00:00","author":"Glossary","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Glossary","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/","name":"Epirubicin - Definition of Epirubicin","isPartOf":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website"},"datePublished":"2022-02-24T05:23:13+00:00","dateModified":"2022-02-24T05:23:13+00:00","author":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5"},"description":"A cytotoxic anthracycline antibiotic drug used in the treatment of solid tumours, acute leukaemia and lymphomas. It is related structurally to doxorubicin and is given intravenously, or by instillation into the urinary bladder\u00a0to treat bladder cancer under specialist supervision.","breadcrumb":{"@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/epirubicin\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.healthbenefitstimes.com\/glossary\/"},{"@type":"ListItem","position":2,"name":"Epirubicin"}]},{"@type":"WebSite","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#website","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/","name":"Glossary","description":"Difinitions","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.healthbenefitstimes.com\/glossary\/?s={search_term_string}"},"query-input":"required name=search_term_string"}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.healthbenefitstimes.com\/glossary\/#\/schema\/person\/ccfef987a4882e6356ae6d77d33e74c5","name":"Glossary","url":"https:\/\/www.healthbenefitstimes.com\/glossary\/author\/adminglossary\/"}]}},"_links":{"self":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/147400","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/comments?post=147400"}],"version-history":[{"count":1,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/147400\/revisions"}],"predecessor-version":[{"id":147401,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/posts\/147400\/revisions\/147401"}],"wp:attachment":[{"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/media?parent=147400"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/categories?post=147400"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.healthbenefitstimes.com\/glossary\/wp-json\/wp\/v2\/tags?post=147400"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}